(S,R,S)-AHPC-PEG2-azide is a high-purity E3 Ligase Ligand-Linker Conjugate designed for advanced PROTAC (Proteolysis Targeting Chimera) drug discovery research. This compound features the active (S,R,S)-AHPC ligand, a potent and selective binder for the VHL (von Hippel-Lindau) E3 ubiquitin ligase, coupled to a PEG2-based linker terminated with an azide group, enabling efficient conjugation via click chemistry. As a key component in PROTAC development, (S,R,S)-AHPC-PEG2-azide facilitates targeted protein degradation by enabling the recruitment of the VHL ligase to specific proteins of interest, leading to their ubiquitination and subsequent proteasomal degradation. This product is ideal for researchers developing novel PROTAC molecules targeting challenging or undruggable proteins in cancer, neurodegenerative diseases, and other therapeutic areas. By incorporating a PEG2-azide linker, it provides enhanced solubility and flexible attachment for a wide variety of warhead chemistries, offering versatility in next-generation drug development programs.
Structure of 2010159-45-0
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Background Introduction
(S,R,S)-AHPC-PEG2-azide is a versatile E3 ligase ligand-linker conjugate widely utilized in PROTAC (Proteolysis Targeting Chimera) technologies. Built around the potent Von Hippel-Lindau (VHL) E3 ligase ligand (AHPC), this molecule features a flexible PEG2 spacer and a terminal azide group. These structural elements enable precise bioconjugation via click chemistry, making it an essential building block for the construction of next-generation PROTAC molecules and other heterobifunctional degraders.
Mechanism
The mechanism of (S,R,S)-AHPC-PEG2-azide centers on targeted protein degradation through the ubiquitin-proteasome system. The AHPC moiety binds selectively to the VHL E3 ubiquitin ligase complex. The PEG2 linker increases solubility and provides optimal spatial arrangement, minimizing steric hindrance. The azide group at the terminus allows for efficient click chemistry conjugation with alkyne-functionalized ligands. In PROTAC assembly, the resultant chimera connects a target protein ligand to the E3 ligase ligand, bringing the target in close proximity to the E3 ligase and promoting ubiquitination and subsequent proteasomal degradation of the target protein.
Applications
(S,R,S)-AHPC-PEG2-azide is a premier tool in the design of PROTACs aimed at targeted protein degradation. It is valuable in preclinical research for developing and optimizing novel PROTAC molecules targeting disease-relevant proteins in oncology, neurodegeneration, and immunology. The azide functionality facilitates rapid prototyping through bio-orthogonal click chemistry, accelerating SAR (structure-activity relationship) studies and enabling the creation of chemical probes, dual-targeting degraders, and other protein homeostasis modulators. This conjugate is also applicable in PROTAC library synthesis, facilitating high-throughput screening of degraders with diverse target profiles.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.